Lantidra
First cellular therapy for patients with type 1 diabetes approved by FDA
June 29, 2023Medical Communications Diabetes, FDA, Lantidra, Type 1 diabetes, diabetes
The US Food and Drug Administration (FDA) has announced that it has approved Lantidra, the first allogeneic (donor) pancreatic islet …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
